BioTelemetry, Inc. Rings The Nasdaq Stock Market Opening Bell in Celebration of Its 10th Listing Anniversary

March 26, 2018

BioTelemetry, Inc. Reports Fourth Quarter 2017 Financial Results

Company Delivers Record Revenue and Adjusted EBITDA Exceeds Expectations

February 22, 2018

BioTelemetry, Inc. to Release Fourth Quarter 2017 Earnings Results on February 22, 2018

BioTelemetry, Inc. (NASDAQ:BEAT) will release its fourth quarter 2017 earnings on Thursday, February 22nd at 4:00 PM Eastern Time.

February 12, 2018

BioTelemetry, Inc. Enters Agreement to Provide Cardiac Monitoring for Apple’s Heart Study

BioTelemetry, Inc. (NASDAQ:BEAT), the leading mobile and wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today a partnership with Apple (NASDAQ:AAPL) to provide cardiac monitoring services in conjunction with the Apple Heart Study.

November 30, 2017

Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management Program

Telcare, the manufacturer of the world’s first FDA-cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo, a joint venture created by Verily (an Alphabet company) and Sanofi. Under this partnership, Telcare will serve as the supplier of remote blood glucose systems and the resulting data for patients enrolled in Onduo’s groundbreaking diabetes management program.

November 27, 2017

BioTelemetry, Inc. Reports Third Quarter 2017 Financial Results

Company Posts Strong Growth with Integration Ahead of Schedule Reports Record Quarterly Revenue and Adjusted EBITDA

November 7, 2017